SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-011346
Filing Date
2024-01-19
Accepted
2024-01-19 17:18:00
Documents
16
Period of Report
2024-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d581989d8k.htm   iXBRL 8-K 28680
2 EX-5.1 d581989dex51.htm EX-5.1 12373
3 EX-10.1 d581989dex101.htm EX-10.1 211776
7 GRAPHIC g581989dsp4.jpg GRAPHIC 8145
8 GRAPHIC g581989dsp4a.jpg GRAPHIC 7845
  Complete submission text file 0001193125-24-011346.txt   458800

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA idya-20240119.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20240119_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20240119_pre.xml EX-101.PRE 11265
10 EXTRACTED XBRL INSTANCE DOCUMENT d581989d8k_htm.xml XML 3366
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 24546462
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)